Breast Tomosynthesis The Use of Breast Tomosynthesis in a Clinical Setting


Since the United States (U.S.) Food and Drug Administration’s (FDA) approval of the first commercial systems in 2000, digital mammography has become an accepted standard of care in breast cancer screening and diagnosis and has paved the way for the newest groundbreaking technology

Related Posts
1 of 156

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy